InsiderTrades

Form 4 for HRTX HERON THERAPEUTICS, INC. /DE/

Accepted 2023-07-17 00:00:00 ET · period of report 2023-07-13 · accession 0001209191-23-042479 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2023-07-17 2023-07-13 HRTX Peraza Lisa VP, CAO F - Tax $1.31 -860 25.3K -3% -$1,127
DM 2023-07-17 2023-07-13 HRTX Peraza Lisa VP, CAO M - OptEx — +2,485 26.2K +10% —
DM 2023-07-17 2023-07-13 HRTX Peraza Lisa VP, CAO M - OptEx $0.00 -2,485 9,896 -20% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2023-07-13 F D 860 $1.31 25,310 D — — (F2) Represents the withholding by the Company of certain of the vested shares of restricted stock to satisfy the minimum statutory tax obligations applicable to such transactions.
2 Common Common Stock 2023-07-13 M A 552 — 24,237 D — — (F1) Restricted stock units convert into common stock on a one-for-one basis.
3 Common Common Stock 2023-07-13 M A 1,933 — 26,170 D — — (F1) Restricted stock units convert into common stock on a one-for-one basis.
4 Derivative Restricted Stock Units 2023-07-13 M D 552 $0.00 2,760 D — · — to — 552 Common Stock (F1) Restricted stock units convert into common stock on a one-for-one basis. (F3) The restricted stock units vest in 16 equal quarterly installments beginning one quarter after the date of grant (10/13/2020).
5 Derivative Restricted Stock Units 2023-07-13 M D 1,933 $0.00 9,896 D — · — to — 1,933 Common Stock (F1) Restricted stock units convert into common stock on a one-for-one basis. (F4) The restricted stock units vest quarterly with 33% of the shares vesting during the first year, 33% of the shares vesting during the second year, 22% of the shares vesting during the third year and the remaining 12% of the shares vesting during the fourth year, such that all shares will be fully vested on the four year anniversary of the date of grant (10/13/2021).